Bharat Biotech’s Intranasal Covid Vaccine approved by Government, to be accessed through CO-WIN

• Bharat Biotech’s intranasal Covid vaccine, BBV154, has been approved by the Drugs Controller General of India for restricted use in an emergency situation for those above 18 as a heterologous booster dose.
• The vaccine will be available to the public through the CO-WIN platform.


Sign Up for NextBigWhat Newsletter

Curated. Summarized. Important News. For free.

You May Also Like